Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond

Purpose: Radiotherapy is integral in the management of hematological malignancies (HM). Standard radiotherapy dose fractionation regimens range between 20 and 50 Gy in 10–25 fractions over 2–5 weeks. This study presents the outcomes of patients with HM treated with hypofractionation radiotherapy (HF...

Description complète

Détails bibliographiques

Auteurs principaux:	Febin Antony, Arbind Dubey, Pamela Skrabek, Lung Fung Tsang, Pascal Lambert, Bohdan Bybel, Naseer Ahmed
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2024-01-01
Collection:	Current Oncology
Sujets:	lymphomas hypofractionation radiotherapy
Accès en ligne:	https://www.mdpi.com/1718-7729/31/1/25
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!